Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial

Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02237348
Contributor : Catherine Sarret <>
Submitted on : Thursday, August 1, 2019 - 12:25:58 PM
Last modification on : Saturday, August 3, 2019 - 1:15:12 AM

Links full text

Identifiers

Citation

Damien Bouvier, David Balayssac, Julie Durif, Charline Mourgues, Catherine Sarret, et al.. Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial. BMJ Open, BMJ Publishing Group, 2019, 9 (5), pp.e027365. ⟨10.1136/bmjopen-2018-027365⟩. ⟨hal-02237348⟩

Share

Metrics

Record views

14